Synergistic interactions between aminoflavone, paclitaxel and camptothecin in human breast cancer cells

by Reinicke, Kathryn E., Kuflel, Mary J., Goetz, Matthew P., Ames, Matthew M.
Published 2009

Gemcitabine Cytotoxicity: Interaction of Efflux and Deamination

by Rudin, Dan, Li, Liang, Niu, Nifang, Kalari, Krishna R., Gilbert, Judith A., Ames, Matthew M., Wang, Liewei
Published 2011

Quantification of the Impact of Enzyme-Inducing Antiepileptic Drugs on Irinotecan Pharmacokinetics and SN-38 Exposure

by Berg, Alexander K., Buckner, Jan C., Galanis, Evanthia, Jaeckle, Kurt A., Ames, Matthew M., Reid, Joel M.
Published in J Clin Pharmacol (2015)

Molecular Markers for Novel Therapeutic Strategies in Pancreatic Endocrine Tumors

by Gilbert, Judith A., Adhikari, Laura J., Lloyd, Ricardo V., Halfdanarson, Thorvardur R., Muders, Michael H., Ames, Matthew M.
Published 2013

Comparative Metabolism of Batracylin (NSC 320846) and N-acetylbatracylin (NSC 611001) Using Human, Dog, and Rat Preparations In Vitro

by Covey, Joseph M, Reid, Joel M, Buhrow, Sarah A, Kuffel, Mary, Walden, Chad, Behrsing, Holger, Ames, Matthew M
Published in J Drug Metab Toxicol (2016)

Mouse pharmacokinetics and metabolism of the curcumin analog, 4-Piperidione,3,5-bis[(2-fluorophenyl)methylene]-acetate(3E,5E) (EF-24; NSC 716993)

by Reid, Joel M., Buhrow, Sarah A., Gilbert, Judith A., Jia, Lee, Shoji, Mamoru, Snyder, James P., Ames, Matthew M.
Published in Cancer Chemother Pharmacol (2014)

Phase I study of tanespimycin in combination with bortezomib in patients with advanced solid malignancies

by Schenk, Erin, Wahner Hendrickson, Andrea E., Northfelt, Donald, Toft, David O., Ames, Matthew M., Menefee, Michael, Satele, Daniel, Qin, Rui, Erlichman, Charles
Published 2013

A Phase 1 and Pharmacokinetic Clinical Trial of Paclitaxel for the Treatment of Refractory Leukemia in Children: A Children’s Oncology Group Study

by Horton, Terzah M., Ames, Matthew M., Reid, Joel M., Krailo, Mark D., Pendergrass, Thomas, Mosher, Revonda, Reaman, Gregory H., Seibel, Nita L.
Published in Pediatr Blood Cancer (2008)

Overcoming S-Phase Checkpoint-Mediated Resistance: Sequence-Dependent Synergy of Gemcitabine and SN-38 In Human Carcinoma Cell Lines

by Gálvez-Peralta, Marina, Dai, Nga T., Loegering, David A., Flatten, Karen, Safgren, Stephanie, Wagner, Jill, Ames, Matthew M., Karnitz, Larry M., Kaufmann, Scott H.
Published 2008

Phase 2 Trial of Pemetrexed in Children and Adolescents with Refractory Solid Tumors: a Children’s Oncology Group Study

by Warwick, Anne B., Malempati, Suman, Krailo, Mark, Melemed, Allen, Gorlick, Richard, Ames, Matthew M., Safgren, Stephanie L., Adamson, Peter C., Blaney, Susan M.
Published 2012

Comparative Uterotrophic Effects of Endoxifen and Tamoxifen in Ovariectomized Sprague Dawley Rats

by Schweikart, Karen M., Eldridge, Sandy R., Safgren, Stephanie L., Parman, Toufan, Reid, Joel M., Ames, Matthew M., Goetz, Matthew P., Davis, Myrtle A.
Published 2014

Toxicology and pharmacokinetics of 1-methyl-[D]-tryptophan: absence of toxicity due to saturating absorption

by Jia, Lee, Schweikart, Karen, Tomaszewski, Joseph, Page, John G., Noker, Patricia E., Buhrow, Sarah A., Reid, Joel M., Ames, Matthew M., Munn, David H.
Published 2007

Phase I Trial of Two Schedules of Vincristine, Oral Irinotecan, and Temozolomide (VOIT) for Children with Relapsed or Refractory Solid Tumors: A Children's Oncology Group Phase I C...

by Wagner, Lars M., Perentesis, John P., Reid, Joel M., Ames, Matthew M., Safgren, Stephanie L., Nelson, Marvin D., Ingle, Ashish M., Blaney, Susan M., Adamson, Peter C.
Published 2010

Gemcitabine and Irinotecan as First-Line Therapy for Carcinoma of Unknown Primary: Results of a Multicenter Phase II Trial

by Holtan, Shernan G., Steen, Preston D., Foster, Nathan R., Erlichman, Charles, Medeiros, Fabiola, Ames, Matthew M., Safgren, Stephanie L., Graham, David L., Behrens, Robert J., Goetz, Matthew P.
Published 2012

Pharmacokinetics of Dacarbazine (DTIC) in Pregnancy

by Kantrowitz-Gordon, Ira, Hays, Karen, Kayode, Olumide, Kumar, Aditya R., Kaplan, Henry G., Reid, Joel M., Safgren, Stephanie L., Ames, Matthew M., Easterling, Thomas R., Hebert, Mary F.
Published in Cancer Chemother Pharmacol (2018)

A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Cent...

by Halfdanarson, Thorvardur R., Foster, Nathan R., Kim, George P., Meyers, Jeffrey P., Smyrk, Thomas C., McCullough, Ann E., Ames, Matthew M., Jaffe, Jeffrry P., Alberts, Steven R.
Published in Oncologist (2019)

Comparative Bioavailability of Sulindac in Capsule and Tablet Formulations

by Reid, Joel M., Mandrekar, Sumithra J., Carlson, Elsa C., Harmsen, W. Scott, Green, Erin M., McGovern, Renee M., Szabo, Eva, Ames, Matthew M., Boring, Daniel, Limburg, Paul J.
Published 2008

Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results

by Santisteban, Marta, Buckner, Jan C., Reid, Joel M., Wu, Wenting, Scheithauer, Bernd W., Ames, Matthew M., Felten, Sara J., Nikcevich, Daniel A., Wiesenfeld, Martin, Jaeckle, Kurt A., Galanis, Evanthia
Published 2008

Coprescription of Tamoxifen and Medications That Inhibit CYP2D6

by Sideras, Kostandinos, Ingle, James N., Ames, Matthew M., Loprinzi, Charles L., Mrazek, David P., Black, John L., Weinshilboum, Richard M., Hawse, John R., Spelsberg, Thomas C., Goetz, Matthew P.
Published 2010

SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen

by Moyer, Ann M, Suman, Vera J, Weinshilboum, Richard M, Avula, Rajeswari, Black, John L, Safgren, Stephanie L, Kuffel, Mary J, Ames, Matthew M, Ingle, James N, Goetz, Matthew P
Published 2011